Nu Skin Enterprises (NYSE:NUS – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 0.950-1.350 for the period, compared to the consensus earnings per share estimate of 1.140. The company issued revenue guidance of $1.7 billion-$1.9 billion, compared to the consensus revenue estimate of $1.8 billion. Nu Skin Enterprises also updated its FY24 guidance to $0.95 to $1.35 EPS.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded Nu Skin Enterprises from a buy rating to a hold rating in a research note on Saturday, February 24th. Four investment analysts have rated the stock with a hold rating, According to MarketBeat, the company has an average rating of Hold and an average price target of $23.67.
Get Our Latest Stock Analysis on NUS
Nu Skin Enterprises Stock Performance
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last announced its earnings results on Wednesday, February 14th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.08. Nu Skin Enterprises had a net margin of 0.44% and a return on equity of 10.73%. The business had revenue of $488.64 million for the quarter, compared to analyst estimates of $479.35 million. Sell-side analysts forecast that Nu Skin Enterprises will post 1.13 earnings per share for the current year.
Nu Skin Enterprises Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, March 6th. Shareholders of record on Monday, February 26th were issued a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 1.93%. The ex-dividend date of this dividend was Friday, February 23rd. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 133.34%.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Read More
- Five stocks we like better than Nu Skin Enterprises
- What Is WallStreetBets and What Stocks Are They Targeting?
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- What Are Dividends? Buy the Best Dividend Stocks
- Generac Powers Ahead on the Electrification Mega-Trend
- Where Do I Find 52-Week Highs and Lows?
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.